Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIV
Author(s) -
Philipp de Leuw,
Christophe Arendt,
Annette E. Haberl,
Daniel Froadinadl,
Gerrit Kann,
Timo Wolf,
Christoph Stephan,
Gundolf Schuettfort,
Moisés Vásquez,
Luca Arcari,
Hui Zhou,
H.A. Zainal,
Monika Gawor,
Eleftherios Vidalakis,
Michael Kolentinis,
Moritz H. Albrecht,
Felicitas Escher,
Thomas J. Vogl,
Andreas M. Zeiher,
Eike Nagel,
Valentina O. Püntmann
Publication year - 2021
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2021.01.042
Subject(s) - medicine , interquartile range , cardiology , myocardial infarction , heart failure , population , cardiac magnetic resonance imaging , clinical endpoint , acute coronary syndrome , magnetic resonance imaging , randomized controlled trial , radiology , environmental health
The goal of this study was to examine prognostic relationships between cardiac imaging measures and cardiovascular outcome in people living with human immunodeficiency virus (HIV) (PLWH) on highly active antiretroviral therapy (HAART).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom